Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid-Reference-Cited by-同舟云学术

Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid

Published:2023-03-31 Issue:1 Volume:55 Page:1156-1170
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Chen Fangyuan¹,Wang Yiman¹,Chen Xinyi¹,Yang Nan²,Li Li¹

Affiliation:

1. Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China

2. Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Milstein Medical Asian American Partnership Foundation

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2188487

Reference103 articles.

1. A Highly Sensitive Enzyme-Linked Immunosorbent Assay for the Detection of Circulating Anti-BP180 Autoantibodies in Patients with Bullous Pemphigoid